ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial

DiscussionAspirin may prevent colorectal cancer through multiple, interrelated mechanisms. The ASPIRED trial will scrutinize these pathways and investigate putative mechanistically based risk-stratification biomarkers.Trial registrationThis protocol is registered with the U.S. National Institutes of Health trial registry, ClinicalTrials.gov, under the identifierNCT02394769. Registered on 16 March 2015.

http://link.springer.com/10.1186/s13063-016-1744-z

Source: Trials - January 31, 2017 Category: Research Source Type: clinical trials